Tocilizumab for the Treatment of Behcet's Syndrome
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Tocilizumab (Primary)
- Indications Behcet's syndrome
- Focus Adverse reactions
- 01 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 01 Oct 2012 New trial record